Sensei Biotherapeutics
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $59M
Investors
- 8
About Sensei Biotherapeutics
Founded in 1999 and based in Maryland, US, Sensei Biotherapeutics, Inc. operates as a biotechnology company that discovers and develops medicines through a vaccine platform to train the immune system, react to specific antigens, and treat immuno-oncology patients. The company's medical R&D team focuses on developing personalized immune therapy for various tumor types and infectious diseases through ImmunoPhage, a platform that engineers non-infectious lambda bacteriophage viruses to display target antigens on the capsid surface, as well as a library of pre-made, clinical-grade bacteriophage vaccines. The product pipeline includes SNS-301, SNS-401, and SNS-VISTA. The company finances operations through a combination of equity offerings, debt financings, collaborations, strategic alliances, distribution, and licensing arrangements. The company plans to list on the Nasdaq global select market under the ticker symbol SNSE.
Who invested in Sensei Biotherapeutics
8 investors across 2 rounds
See all investors in Sensei Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sensei Biotherapeutics
Who invested in Sensei Biotherapeutics?
Sensei Biotherapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sensei Biotherapeutics raised?
Sensei Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sensei Biotherapeutics last raise money?
Sensei Biotherapeutics's most recent round on record is a Series B, in Jan 2021.
What does Sensei Biotherapeutics do?
Founded in 1999 and based in Maryland, US, Sensei Biotherapeutics, Inc.
Where is Sensei Biotherapeutics headquartered?
Sensei Biotherapeutics is headquartered in Rockville, US.
Which VCs invest in companies like Sensei Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sensei Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sensei Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.